Oncology Data Management (ODM) Market – Trends Forecast Till 2031

Market Snapshot

Market Overview

The global Oncology Data Management (ODM) Market size was estimated at USD 7500 million in 2024 and is projected to reach USD 11,835.5 million in 2031 at a CAGR of 7.90 % during the forecast period 2025-2031.

Oncology Data Management (ODM) refers to the collection, processing, and management of data related to cancer research, clinical trials, and patient outcomes. It involves the integration of various data sources such as patient records, diagnostic imaging, genomic data, and treatment history. The goal of ODM is to provide accurate, real-time information that can support cancer research, enhance clinical decision-making, and optimize treatment protocols. With advancements in healthcare technology, the ODM market is increasingly relying on sophisticated data systems, including electronic health records (EHR), clinical trial management systems (CTMS), and cloud-based solutions to manage the vast amount of cancer-related data.

The scope of the ODM market is expansive, as it includes multiple stakeholders, including hospitals, research institutions, pharmaceutical companies, and contract research organizations (CROs). These players rely on ODM systems to handle and analyze large datasets, improving the efficiency and accuracy of cancer research and clinical trials. With the global increase in cancer incidences, the demand for innovative data management solutions that can handle diverse and complex data sets is rising. The market is also driven by the need for personalized medicine, where data management plays a crucial role in tailoring treatment strategies to individual patients based on their genetic makeup and other factors.

Several trends are shaping the ODM market, including the growing adoption of artificial intelligence (AI) and machine learning (ML) technologies. These technologies are enabling more accurate data analysis, pattern recognition, and predictive analytics, allowing healthcare providers to better understand cancer biology and improve treatment outcomes. Another significant trend is the move toward data interoperability, where different systems and platforms are designed to seamlessly exchange information. This allows for a more holistic view of patient data, which is essential for advancing precision oncology and ensuring that the right treatments are administered at the right time.

The drivers of the ODM market include the increasing prevalence of cancer, the demand for more efficient and data-driven clinical trials, and the continuous evolution of healthcare IT infrastructure. As cancer rates rise globally, there is a greater need for robust data management systems that can support the growing volume of cancer-related information. Additionally, regulatory requirements and the push for more transparent and reproducible research outcomes further fuel the adoption of advanced data management solutions. With continuous technological advancements, including the integration of big data, cloud computing, and next-generation sequencing technologies, the ODM market is set to expand rapidly in the coming years.

Delvens Industry Expert's Standpoint

Experts in the Oncology Data Management (ODM) Market highlight several key trends driving growth and innovation. Oncology Data Management (ODM) involves the collection, processing, and management of cancer-related data from sources like patient records, imaging, genomic data, and treatment history. Its primary goal is to support cancer research, improve clinical decision-making, and optimize treatments. The market is driven by the increasing prevalence of cancer, the need for personalized medicine, and advancements in healthcare technologies such as AI, machine learning, and cloud computing. Key trends include data interoperability and the adoption of advanced data systems to enhance research efficiency and precision oncology. With growing cancer rates and evolving regulatory requirements, the ODM market is expanding rapidly, offering innovative solutions to manage complex cancer data.

Market Portfolio

Key Findings

• The solutions segment holds the largest share of the global market, driven by the growing adoption of oncology information systems (OIS) by healthcare providers. These solutions play a crucial role in the management of radiology imaging, capturing cancer patient-reported outcomes, and facilitating direct communication between patients and healthcare providers. This segment is experiencing rapid growth due to advancements in OIS technology, which enhances patient data management and cancer treatment. The treatment planning systems within this segment contribute significantly to its market dominance, helping to streamline and improve cancer care delivery. Additionally, the increasing reliance on these solutions is expected to continue as healthcare systems demand more efficient data management tools.

• The professional services segment is growing steadily as more hospitals and clinics opt to outsource OIS services, mainly due to a shortage of skilled professionals. These services offer online consultations, customized schedules, and reports, improving overall care quality. The demand for specialized services has risen as healthcare institutions focus on improving operational efficiency and enhancing patient outcomes. This trend is further supported by the increasing complexity of oncology treatments and the need for more tailored approaches, which outsourcing professional services can provide. As a result, this segment is expanding in response to healthcare institutions seeking to optimize their resources while maintaining high standards of care.

• The medical oncology segment is the dominant application in the global market, driven by significant progress in immunotherapy, hormonal therapy, and targeted therapy. This segment is expected to maintain strong growth due to continuous research and advancements in cancer treatment options. The increasing availability and effectiveness of these therapies offer better management of various types of cancers, leading to a surge in their adoption. Additionally, initiatives from key players focused on advancing cancer research contribute positively to this growth, as new treatments and therapies continue to emerge, enhancing patient outcomes and survival rates.

• The surgical oncology segment is also poised for significant growth, driven by the increasing complexity of cancer surgeries and the combination of surgery with other treatments like radiotherapy and chemotherapy. While surgery alone is no longer the preferred treatment for most cancers, it remains an integral part of a multi-modal treatment approach, particularly for solid malignancies. The need for specialized procedures, such as laparoscopic cancer surgery and cytoreductive surgery, is increasing as cancer care becomes more advanced. This growing complexity is expected to drive the demand for surgical oncology services, particularly in highly specialized healthcare centers, further expanding the market during the forecast period.

• The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America region is projected to hold the largest market share. Factors such as increasing cancer prevalence, advancements in healthcare IT, demand for personalized medicine, AI and machine learning adoption, expansion of clinical trials, regulatory pressures, genomic sequencing advancements, big data and cloud integration, improved data interoperability, and higher healthcare investments in oncology research have triggered the Oncology Data Management (ODM) Market in the region.

Regional Analysis

North America to Dominate the Market

• The North America regional market held the largest revenue share of 38.3%. This growth can be attributed to the region's advanced healthcare infrastructure and the increasing focus on patient information management. The rising adoption of Oncology Information Systems (OIS) to track and document cancer treatment outcomes, along with the growing reliance on Electronic Medical Records (EMR) for improved treatment decisions, is expected to further drive market growth. Additionally, the increasing demand for managing treatment schedules, doses, and planning is anticipated to boost the need for OIS in the region.

Competitive Landscape

• Elekta AB
• Accuray Inc.
• Varian Medical Systems
• RaySearch Laboratories
• Cerner Corp.
• BrainLab
• Philips Healthcare
• Prowess, Inc.
• DOSIsoft S.A.
• ViewRay Inc.
• MIM Software
• Flatiron
• McKesson Corporation
• Siemens Medical Solutions, Inc.

Recent Developments

• In August 2021, Siemens Healthineers acquired Varian Medical Systems to form a distinct, integrated portfolio of oncology information system workflows.

• In June 2021, Koninklijke Philips N.V. collaborated with Elekta to advance personalized cancer care through precision oncology information solutions.

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
• Gain authentic and granular data access for the Oncology Data Management (ODM) Market to understand the trends and the factors involved in changing market situations.
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope